| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
Is Necessary for Smad3 Expression and Transforming Growth Factor ßInduced Fibronectin Synthesis in Vascular Smooth Muscle Cells
From the Division of Vascular Surgery (E.J.R., R.P.H., K.S., P.L.F., B.L., K.C.K.), New York Presbyterian Hospital, Cornell University, Weill Medical School and Columbia University, College of Physicians and Surgeons, New York, NY; the Department of Molecular and Cellular Biology (K.I.N.), Medical Institute of Bioregulation, Kyushu University, Japan; and the Department of Developmental Biology (K.N.), Graduate School of Medicine, Tohoku University School of Medicine, Japan.
Correspondence to K. Craig Kent, MD, Department of Surgery, New York Presbyterian Hospital, Weill Medical College, Cornell University, 525 E 68th St, Room 707, New York, NY 10021. E-mail kckent{at}med.cornell.edu
Objective The purpose of these studies is to investigate the mechanism by which transforming growth factor (TGF)ß1 regulates the synthesis of the extracellular matrix protein fibronectin (FN).
Methods and Results TGFß1 elicited a time-dependent induction of FN protein and mRNA in A10 rat aortic smooth muscle cells (SMCs). Ectopic expression of Smad3 in A10 cells stimulated both basal and TGFß1-induced FN expression, whereas expression of Smad7 eliminated the TGFß response. Because TGFß activated PKC
in SMCs, we tested the role of PKC
in regulation of FN expression. Inhibition of PKC
activity by rottlerin or dominant-negative adenovirus (AdPKC
DN) blocked TGFß1s induction of FN, whereas overexpression of PKC
enhanced TGFßs effect. Moreover, aortic SMCs isolated from PKC
/ mice exhibited diminished FN induction in response to TGFß. Furthermore, we found that Smad3 protein and mRNA were markedly reduced in AdPKC
DN-treated A10 cells and in PKC
null cells. Finally, restoring Smad3 in rottlerin-treated A10 and PKC
null cells rescues the ability of TGFß to upregulate FN protein and mRNA expression.
Conclusion Our data suggest that TGFß-activated PKC
is critical to maintain normal expression of Smad3, which in turn is required for the induction of fibronectin. PKC
represents a promising target for treating the fibroproliferative response after arterial injury.
The mechanism by which TGFß regulates the synthesis of fibronectin remains inconclusive. Our data suggest that TGFß-activated PKC
is critical to maintain Smad3 levels, which in turn are required for fibronectin expression. Thus, PKC
may serve as a novel therapeutic target to prevent the fibroproliferative response after arterial injury.
Key Words: extracellular matrix fibronectin intimal hyperplasia protein kinase C delta TGF beta
This article has been cited by other articles:
![]() |
H. Nakashima, G. D. Frank, H. Shirai, A. Hinoki, S. Higuchi, H. Ohtsu, K. Eguchi, A. Sanjay, M. E. Reyland, P. J. Dempsey, et al. Novel Role of Protein Kinase C-{delta} Tyr311 Phosphorylation in Vascular Smooth Muscle Cell Hypertrophy by Angiotensin II Hypertension, February 1, 2008; 51(2): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamiya, K. Sakakibara, E. J. Ryer, R. P. Hom, E. B. Leof, K. C. Kent, and B. Liu Phosphorylation of the Cyclic AMP Response Element Binding Protein Mediates Transforming Growth Factor {beta}-Induced Downregulation of Cyclin A in Vascular Smooth Muscle Cells Mol. Cell. Biol., May 1, 2007; 27(9): 3489 - 3498. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khan, A. Agrotis, and A. Bobik Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury Cardiovasc Res, May 1, 2007; 74(2): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |